HARROW, INC. — Director's Dealing 2023

Sep 21, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARROW HEALTH, INC. (HROW)
CIK: 0001360214
Period of Report: 2023-09-19

Reporting Person: Opaleye Management Inc. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-09-19	Common Stock, par value $0.001 per share	P	14017	$14.6512	Acquired	3614017	Indirect
2023-09-20	Common Stock, par value $0.001 per share	P	5983	$14.4928	Acquired	3620000	Indirect

Footnotes

F1: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.

F2: The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume-weighted average purchase price of $14.6512. The range of purchase prices per share on the transaction date was $14.59 to $14.73. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.

F3: The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume-weighted average purchase price of $14.4928. The range of purchase prices per share on the transaction date was $14.22 to $14.67. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.